PDCD1 and lung carcinoma: Although the current study provided the new insight of therapeutic strategy for KL lung cancer tumors, however, several limitations and further investigations need to be acknowledged: (i) KP tumors responded well to PD-1 blockade, however, the impact of FAK inhibitor on KP tumors remained unclear.